| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/12/2009 | US20090069295 Deuterium-enriched conivaptan |
| 03/12/2009 | US20090069294 Organic Compounds |
| 03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
| 03/12/2009 | US20090068751 Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes |
| 03/12/2009 | US20090065057 Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof |
| 03/11/2009 | EP2033963A1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2032580A2 Long lived anion-selective sensors based on a covalently attached metalloporphyrin as anion receptor |
| 03/11/2009 | EP2032579A2 Process useful in the preparation of morphinan antagonists |
| 03/11/2009 | EP2032578A2 Triazolopyridazine derivatives |
| 03/11/2009 | EP2032577A1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 03/11/2009 | EP2032576A1 Process for the demethylat i on of oxycodone and related compounds |
| 03/11/2009 | EP2032142A2 Novel compounds |
| 03/11/2009 | EP2032140A1 Pyrrolo[1,2-a]pyrazin-1(2h)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2h)-one derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 03/11/2009 | EP2031965A2 Novel compounds |
| 03/11/2009 | EP1789416B1 Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1165564B1 Process for preparing inhibitors of nucleoside metabolism |
| 03/11/2009 | CN101384600A Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol |
| 03/11/2009 | CN101384599A Heterocyclic antiviral compounds |
| 03/11/2009 | CN101384598A Organic compound, anisotropic optical film and method of production thereof |
| 03/11/2009 | CN101384597A 6,7-dihydrobenzimidazo[1 ,2-c]quinazolin-6-one carboxylic acids, their esters, and methods of synthesis thereof |
| 03/11/2009 | CN101384596A Heterocylic antiviral compounds |
| 03/11/2009 | CN101384595A Salt of CD 80 antagonist |
| 03/11/2009 | CN101384594A Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 03/11/2009 | CN101384586A Pi-3 kinase inhibitors and methods of their use |
| 03/11/2009 | CN101384583A Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 03/11/2009 | CN101381369A 5-dichloroacetyl-3,6-dimethyl-3-ethyl-9-oxa-1,5-diazabicyclo[4.3.0]nonane and synthetic method |
| 03/11/2009 | CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 03/11/2009 | CN100467543C Fluorinated dyes or colorants and their uses |
| 03/11/2009 | CN100467471C Method for producing zopiclone |
| 03/11/2009 | CN100467467C 2,4-dioxopyrimidine-based mesoionic pigments |
| 03/10/2009 | US7501523 reacting an oligomer consisting of 2-11 linked glycolurils or analogues with one or more compounds selected from glycoluril, glycoluril analogues and/or oligomers of glycoluril or glycoluril analogues, in the presence of an acid, and a template (dimethylaminobenzaldehyde) to form a cucurbit(n)uril |
| 03/10/2009 | US7501512 Chemical compounds |
| 03/10/2009 | US7501510 N,N'-disubstituted thiourea ligand, when complexed with palladium forms a catalyst useful for Heck reaction of arylhalides and olefins and Suzuki cross-coupling reaction of aryl halides with aryl boric acids |
| 03/10/2009 | US7501507 condensing a 5-acetaldipyrromethane with a dipyrromethane-1,9-dicarbinol to produce a porphyrin having an acetal group substituted thereon at the 5 position; and then hydrolyzing said porphyrin to produce said 5-formylporphyrin |
| 03/10/2009 | US7501427 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
| 03/10/2009 | US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis |
| 03/10/2009 | US7501419 4-Squarylpiperazine derivatives as antiviral agents |
| 03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 03/10/2009 | US7501411 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 03/10/2009 | US7501409 A tablet has an acid, with reduced solubility in the neutral and alkaline regions, is used for treating sexual disorders erectile dysfunction |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501383 Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use for controlling harmful fungi |
| 03/10/2009 | US7501076 Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance |
| 03/10/2009 | CA2468649C Adenosine a2a receptor antagonists |
| 03/10/2009 | CA2258768C A process for the preparation of tetraazamacrocycles |
| 03/05/2009 | WO2009029625A1 4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors |
| 03/05/2009 | WO2009029617A1 Diarylamine-substituted quinolones useful as inducible nitric oxide synthase inhibitors |
| 03/05/2009 | WO2009029592A1 Heterobicyclic-substituted quinolones useful as nitric oxide synthase inhibitors |
| 03/05/2009 | WO2009029384A2 Compounds for the treatment of hepatitis c |
| 03/05/2009 | WO2009028588A1 Polycyclic compound |
| 03/05/2009 | WO2009028478A1 Phthalocyanine compound |
| 03/05/2009 | WO2009027965A1 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| 03/05/2009 | WO2009027733A1 (2-pyridin-3-ylimidazo[1,2-b]pyridazin-6-yl) urea derivatives as antibacterial agents |
| 03/05/2009 | WO2009027730A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | WO2009010298A8 Paullone derivatives and its use |
| 03/05/2009 | WO2009005690A3 Antiviral compounds |
| 03/05/2009 | WO2009005677A3 Antiviral compounds |
| 03/05/2009 | WO2009005676A3 Antiviral compounds |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/05/2009 | US20090062529 Multi-cyclic compounds |
| 03/05/2009 | US20090062318 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| 03/05/2009 | US20090062312 Deuterium-enriched indiplon |
| 03/05/2009 | US20090062298 Deuterium-enriched sildenafil |
| 03/05/2009 | US20090062292 4-((R)-5-cyclopentyl-4-ethyl-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridin-7-ylamino)-3-methoxy-N-methylbenzamide, useful for treating or preventing autoimmune, inflammatory, proliferative, or hyperproliferative disease, a neurodegenerative disease, or an immunologically-mediated disease |
| 03/05/2009 | US20090062290 Heterocycles as potassium channel modulators |
| 03/05/2009 | US20090062289 Immunomodulating oxopyrrazolocinnolines as cd 80 inhibitors |
| 03/05/2009 | US20090062286 Crystal Structure of SMYD3 Protein |
| 03/05/2009 | US20090062265 6-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-7-fluoro-5,6-dihydro-3H-pyrrolo[1,2,3-de]quinoxalin-3-one; may be formulated for administration in any convenient way for use in human or veterinary medicine |
| 03/05/2009 | US20090062257 Deuterium-enriched varenicline |
| 03/05/2009 | US20090062256 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 03/05/2009 | US20090062255 Tumor-targeting evaluation methodology and compounds related thereto |
| 03/05/2009 | US20090062253 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 03/05/2009 | CA2698552A1 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| 03/05/2009 | CA2698018A1 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| 03/05/2009 | CA2697971A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | CA2696609A1 Therapeutic isoxazole compounds |
| 03/05/2009 | CA2695781A1 Compounds for the treatment of hepatitis c |
| 03/04/2009 | EP2029607A1 Novel 8,10-diaza-bicycloý4.3.1¨decane derivatives and their medical use |
| 03/04/2009 | EP2029606A2 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 03/04/2009 | EP2029605A1 Imidazopyrazines as protein kinase inhibitors |
| 03/04/2009 | EP2029604A2 Aldosterone synthase and/or 11beta-hydroxylase inhibitors |
| 03/04/2009 | EP2029603A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor |
| 03/04/2009 | EP2029602A2 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 03/04/2009 | EP2029601A1 Pyridopyrimidinone derivatives |
| 03/04/2009 | EP2029592A1 Pharmaceutical compounds |
| 03/04/2009 | EP2029589A1 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
| 03/04/2009 | EP2029551A2 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/04/2009 | EP2029539A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 03/04/2009 | EP2029532A2 Piperazine enamines as antiviral agents |
| 03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
| 03/04/2009 | EP2029142A1 Composition for induction or inhibition of stem cell differentiation |
| 03/04/2009 | EP1869049B1 Imidazopyridazine compounds |
| 03/04/2009 | EP1601649A4 A1 adenosine receptor antagonists |
| 03/04/2009 | EP1551812B1 Mitotic kinesin inhibitors |
| 03/04/2009 | EP1546150B1 Pyrrole derivatives as inhibitors of cyteine proteases |
| 03/04/2009 | EP1392312B1 TRIAZOLO 4,5-d PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 03/04/2009 | EP1379269B1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 03/04/2009 | CN101379066A HCV NS5B inhibitors |